| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $8.2M | -80.5% |
| SG&A Expense | $5.9M | -64.7% |
| Operating Income | -$14.1M | +52.6% |
| Interest Expense | $430K | — |
| Pre-tax Income | -$17.4M | +29.0% |
| Income Tax | $0 | — |
| Net Income | -$17.4M | +29.0% |
| EPS (Basic) | -$7.83 | -2800.0% |
| EPS (Diluted) | -$7.83 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.6M | +380.6% |
| Accounts Receivable | $358K | -37.4% |
| Current Assets | $88.2M | +128.1% |
| Total Assets | $88.2M | +128.1% |
| Current Liabilities | $12.0M | +1.0% |
| Total Liabilities | $25.6M | +115.0% |
| Stockholders' Equity | $62.6M | +134.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.8M | +79.9% |
| Financing Cash Flow | $87.1M | +340.0% |
| -460.8% |